Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grant Dewson

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Cell Death and Differentiation|September 28, 2022
Mitochondrial E3 ubiquitin ligase MARCHF5 controls BAK apoptotic activity independently of BH3-only proteinsAllan Shuai Huang, Hui San Chin, Boris Reljic, et al.
Nature|March 16, 2022
Publisher Correction: Activation mechanism of PINK1Zhong Yan Gan, Sylvie Callegari, Simon A Cobbold, et al.
The EMBO Journal|December 22, 2018
Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagyJonathan P Bernardini, Jason M Brouwer, Iris Kl Tan, et al.
Molecular Cell|April 1, 2021
Structure of detergent-activated BAK dimers derived from the inert monomerRichard W Birkinshaw, Sweta Iyer, Daisy Lio, et al.
Blood|September 11, 2010
Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also BimLina Happo, Mark S Cragg, Belinda Phipson, et al.
Blood|October 4, 2017
A critical epithelial survival axis regulated by MCL-1 maintains thymic function in miceReema Jain, Julie M Sheridan, Antonia Policheni, et al.
Elife|December 15, 2023
Trabid patient mutations impede the axonal trafficking of adenomatous polyposis coli to disrupt neurite growthDaniel Frank, Maria Bergamasco, Michael J Mlodzianoski, et al.
Plos Biology|May 2, 2024
Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosisZheng Yuan, Mark F van Delft, Mark Xiang Li, et al.
Cell|February 5, 2013
Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosisPeter E Czabotar, Dana Westphal, Grant Dewson, et al.
Genes & Development|October 28, 2018
Mutant TRP53 exerts a target gene-selective dominant-negative effect to drive tumor developmentBrandon J Aubrey, Ana Janic, Yunshun Chen, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Cell Death and Differentiation|September 28, 2022
Mitochondrial E3 ubiquitin ligase MARCHF5 controls BAK apoptotic activity independently of BH3-only proteinsAllan Shuai Huang, Hui San Chin, Boris Reljic, et al.
Nature|March 16, 2022
Publisher Correction: Activation mechanism of PINK1Zhong Yan Gan, Sylvie Callegari, Simon A Cobbold, et al.
The EMBO Journal|December 22, 2018
Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagyJonathan P Bernardini, Jason M Brouwer, Iris Kl Tan, et al.
Molecular Cell|April 1, 2021
Structure of detergent-activated BAK dimers derived from the inert monomerRichard W Birkinshaw, Sweta Iyer, Daisy Lio, et al.
Blood|September 11, 2010
Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also BimLina Happo, Mark S Cragg, Belinda Phipson, et al.
Blood|October 4, 2017
A critical epithelial survival axis regulated by MCL-1 maintains thymic function in miceReema Jain, Julie M Sheridan, Antonia Policheni, et al.
Elife|December 15, 2023
Trabid patient mutations impede the axonal trafficking of adenomatous polyposis coli to disrupt neurite growthDaniel Frank, Maria Bergamasco, Michael J Mlodzianoski, et al.
Plos Biology|May 2, 2024
Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosisZheng Yuan, Mark F van Delft, Mark Xiang Li, et al.
Cell|February 5, 2013
Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosisPeter E Czabotar, Dana Westphal, Grant Dewson, et al.
Genes & Development|October 28, 2018
Mutant TRP53 exerts a target gene-selective dominant-negative effect to drive tumor developmentBrandon J Aubrey, Ana Janic, Yunshun Chen, et al.
Pageof 8